PI5P4K inhibitor (Weill Cornell Medical College)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePI5P4K inhibitor (Weill Cornell Medical College)
Drug Alias Namephosphatidylinositol-5-phosphate 4-kinases inhibitor (Weill Cornell Medical College)
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionPhosphatidylinositol 4-kinase inhibitors
TargetsPhosphatidylinositol 4-kinase
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeill Medical College of Cornell University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWeill Medical College of Cornell University
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A